The Associated Press Health Amp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA OKs first new ADHD drug in over a decade for children
LINDA A. JOHNSON, Associated Press
April 5, 2021
FacebookTwitterEmail
This undated image provided by Supernus Pharmaceuticals in April 2021 shows bottles for different dosages of the drug Qelbree. On Friday, April 2, 2021, the U.S. Food and Drug Administration approved the medication for treating attention deficit hyperactivity disorder in children ages six through 17. (Supernus Pharmaceuticals via AP)AP
U.S. regulators have approved the first new drug in over a decade for children with ADHD, which causes inattention, hyperactivity and impulsivity.
The Food and Drug Administration late Friday OK’d Qelbree (KELL’-bree) for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that’s taken daily. ....

United States , Lindaa Johnson , Davidw Goodman , Johns Hopkins School Of Medicine , Psychiatric Associates , Health Science Department , Supernus Pharmaceuticals Of Rockville , Supernus Pharmaceuticals , Suburban Psychiatric Associates , Johns Hopkins School , Associated Press Health , Science Department , Howard Hughes Medical Institute , North America , Mc Complete State National , Premium Entertainment , Department Of Science Education , A Wire , Business Stories , News Health Stories , The Associated Press Health Amp , Adhd Drug , Top News , Business News , Mc Complete Agate Extras , Choice Plus ,